Monday November 23 2009 | Biotechnology feed | All feeds
|
|
|
CollaGenex Pharmaceutical
Download detailed PDF Members: ollaGenex Pharmaceuticals, Inc. is a pharmaceutical company focused on providing innovative medical therapies for the treatment of periodontitis and other pathologies characterized by the progressive degradation of the body's connective tissues. The Company's core technology involves inhibiting the activity of certain enzymes that degrade such connective tissues. The Company's first product, Periostat(R), is a prescription pharmaceutical capsule that was approved by the United States Food and Drug Administration (the "FDA") in September 1998 as an adjunct to scaling and root planning ("SRP"), the most prevalent non-surgical therapy for adult periodontitis, to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis. Adult periodontitis, a chronic disease characterized by theprogressive loss of attachment between the tooth root and the surrounding periodontal structures due to chronic progressive connective tissue degradation, may result in tooth loss if untreated..
This page has been viewed 464 times since April 2007, the link to the organisation's website has been followed 77 times Recent Search Terms used to find this page: collagenex news july 2009 | collagenex pharmaceutical | collagenex pharmaceutical | . Search for more companies in Newtown Search for more companies in PA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for CollaGenex Pharmaceutical | ||||||||||||||||||||||||||||||||||||||||||||
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
